Cargando…

A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City

BACKGROUND: Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs (PWUD). It is still unclear, however, how the adoption of risk-reduction practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beharie, Nisha, Urmanche, Adelya, Harocopos, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039575/
https://www.ncbi.nlm.nih.gov/pubmed/36966342
http://dx.doi.org/10.1186/s12954-023-00772-3
_version_ 1784912297470197760
author Beharie, Nisha
Urmanche, Adelya
Harocopos, Alex
author_facet Beharie, Nisha
Urmanche, Adelya
Harocopos, Alex
author_sort Beharie, Nisha
collection PubMed
description BACKGROUND: Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs (PWUD). It is still unclear, however, how the adoption of risk-reduction practices has differed among PWUD in the context of increasing presence of non-pharmaceutical fentanyl in the drug supply. This study aims to assess the adoption of risk-reduction tools (e.g., naloxone) among those engaged with SSP services and those not engaged with SSP services. METHODS: We conducted a mixed-methods study following a convergent parallel design integrating both quantitative and qualitative data. Interviews were conducted with 80 people who used street opioids (i.e., heroin or opioid pills not prescribed), 32 of whom were not engaged in SSP services. Quantitative differences between those engaged and those not engaged in SSPs were assessed using independent samples t tests and Fisher’s exact tests. A thematic analytic approach was employed to compare qualitative responses between the two groups. RESULTS: Three main themes emerged in our analysis: (1) Both groups expressed an interest in fentanyl test strips (FTS), but those engaged in SSP services found them to be more accessible; (2) there was greater adoption of and enthusiasm for naloxone among SSP participants; and (3) SSP participants were more likely to have or be interested in having someone check in on them when using alone, but stigma and perceived personal risk of overdose prevented widespread adoption of this practice among all participants. CONCLUSION: SSPs provide a vital function by facilitating naloxone and FTS distribution to participants who often have little control over their exposure to fentanyl. However, stigma and misconceptions regarding drug use are barriers to people adopting risk-reduction practices, particularly among those not engaged with SSPs.
format Online
Article
Text
id pubmed-10039575
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100395752023-03-26 A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City Beharie, Nisha Urmanche, Adelya Harocopos, Alex Harm Reduct J Research BACKGROUND: Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs (PWUD). It is still unclear, however, how the adoption of risk-reduction practices has differed among PWUD in the context of increasing presence of non-pharmaceutical fentanyl in the drug supply. This study aims to assess the adoption of risk-reduction tools (e.g., naloxone) among those engaged with SSP services and those not engaged with SSP services. METHODS: We conducted a mixed-methods study following a convergent parallel design integrating both quantitative and qualitative data. Interviews were conducted with 80 people who used street opioids (i.e., heroin or opioid pills not prescribed), 32 of whom were not engaged in SSP services. Quantitative differences between those engaged and those not engaged in SSPs were assessed using independent samples t tests and Fisher’s exact tests. A thematic analytic approach was employed to compare qualitative responses between the two groups. RESULTS: Three main themes emerged in our analysis: (1) Both groups expressed an interest in fentanyl test strips (FTS), but those engaged in SSP services found them to be more accessible; (2) there was greater adoption of and enthusiasm for naloxone among SSP participants; and (3) SSP participants were more likely to have or be interested in having someone check in on them when using alone, but stigma and perceived personal risk of overdose prevented widespread adoption of this practice among all participants. CONCLUSION: SSPs provide a vital function by facilitating naloxone and FTS distribution to participants who often have little control over their exposure to fentanyl. However, stigma and misconceptions regarding drug use are barriers to people adopting risk-reduction practices, particularly among those not engaged with SSPs. BioMed Central 2023-03-25 /pmc/articles/PMC10039575/ /pubmed/36966342 http://dx.doi.org/10.1186/s12954-023-00772-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Beharie, Nisha
Urmanche, Adelya
Harocopos, Alex
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title_full A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title_fullStr A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title_full_unstemmed A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title_short A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
title_sort mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in new york city
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039575/
https://www.ncbi.nlm.nih.gov/pubmed/36966342
http://dx.doi.org/10.1186/s12954-023-00772-3
work_keys_str_mv AT beharienisha amixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity
AT urmancheadelya amixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity
AT harocoposalex amixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity
AT beharienisha mixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity
AT urmancheadelya mixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity
AT harocoposalex mixedmethodsanalysisofriskreductionstrategiesadoptedbysyringeservicesprogramparticipantsandnonsyringeservicesprogramparticipantsinnewyorkcity